论文信息 - Phase I study of chidamide (CS055/HBI-8000), a novel histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas. - 字舞流文

Phase I study of chidamide (CS055/HBI-8000), a novel histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas.

M. J. Newman | Z. Ning | X. Lu | M. Dong | J. Xu | G. Dou | H. Cao | Y. Shi | M. Gingras | F. Feng